• HealthSpan Partners raised its cash acquisition price for Surgery Partners to $25 per share, valuing the transaction at up to approximately $6 billion.
• Non-Bain shareholders qualify for delay payments accruing at 10% annually if shareholder approval is obtained but closing occurs after March 1, 2027.
• Consideration reaches $26.61 per share, including $1.61 in delay payments, if approval precedes March 1 and closing occurs October 23, 2027.
• The special committee rejected a competing $28-per-share cash proposal, citing greater closing uncertainty, regulatory complexity and inadequate contractual protections.
• Closing remains expected in the first quarter of 2027; Bain Capital will roll over its approximately 39% stake rather than receive cash.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Surgery Partners Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611090830BIZWIRE_USPR_____20261109_BW695957) on November 09, 2026, and is solely responsible for the information contained therein.